MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Share-based Compensation (2015 - 2026)

MetaVia's (MTVA) quarterly Share-based Compensation came in at $71000.0 in Q4 2025, up 914.29% YoY from $7000.0 in Q4 2024, and down 76.33% on a QoQ basis from $300000.0 in Q3 2025.

MetaVia (MTVA) Share-based Compensation (2015 - 2026) Analysis & Trends

MetaVia (MTVA) has 11 years of Share-based Compensation data on file, last reported at $71000.0 in Q4 2025.

  • Quarterly Share-based Compensation rose 914.29% year-over-year to $71000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $328000.0 (down 15.03% YoY) and the FY2025 annual result came in at $411000.0, down 31.5% from the prior year.
  • Share-based Compensation fell to $71000.0 in Q4 2025, from $300000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $400000.0 in Q1 2025 to a low of -$74000.0 in Q1 2023.
  • A 5-year average of $150350.0 and a median of $155500.0 in 2023 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2023 — Share-based Compensation slumped 135.75% — and 2025, when it jumped 914.29%.
  • Tracing MTVA's Share-based Compensation over 5 years: stood at $188000.0 in 2021, then grew by 15.96% to $218000.0 in 2022, then tumbled by 53.67% to $101000.0 in 2023, then tumbled by 93.07% to $7000.0 in 2024, then jumped by 914.29% to $71000.0 in 2025.
  • The last three Share-based Compensation figures came in at $71000.0 (Q4 2025), $300000.0 (Q3 2025), and $111000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 120.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 137.41 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 86.63 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 28.05 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 41.25 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 MetaVia 8.72 Mn -3.92 Mn - 130,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 130,000.00
Jun 30, 2026 130,000.00
Dec 31, 2025 71,000.00
Dec 31, 2025 71,000.00
Sep 30, 2025 300,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 111,000.00
Jun 30, 2025 111,000.00
Mar 31, 2025 400,000.00
Mar 31, 2025 400,000.00
Dec 31, 2024 7,000.00
Dec 31, 2024 7,000.00
Sep 30, 2024 139,000.00
Sep 30, 2024 139,000.00
Jun 30, 2024 135,000.00
Jun 30, 2024 135,000.00
Mar 31, 2024 105,000.00
Mar 31, 2024 105,000.00
Dec 31, 2023 101,000.00
Dec 31, 2023 101,000.00